These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 27214765)
21. Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide. Badiyan SN; Markovina S; Simpson JR; Robinson CG; DeWees T; Tran DD; Linette G; Jalalizadeh R; Dacey R; Rich KM; Chicoine MR; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):877-85. PubMed ID: 25257812 [TBL] [Abstract][Full Text] [Related]
22. Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme. Hashem SA; Salem A; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Rejeeth C; Mohamad I; Sughayer M; Elyan M; Al-Hussaini M; Addasi A; Almousa A J Med Imaging Radiat Oncol; 2012 Apr; 56(2):204-10. PubMed ID: 22498195 [TBL] [Abstract][Full Text] [Related]
23. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709 [TBL] [Abstract][Full Text] [Related]
24. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients. Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780 [TBL] [Abstract][Full Text] [Related]
25. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983 [TBL] [Abstract][Full Text] [Related]
26. Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma. Yusuf M; Ugiliweneza B; Amsbaugh M; Boakye M; Williams B; Nelson M; Hattab EM; Woo S; Burton E Oncology; 2018; 95(1):39-42. PubMed ID: 29694955 [TBL] [Abstract][Full Text] [Related]
27. Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients. Wang TJ; Jani A; Estrada JP; Ung TH; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Isaacson SR; Cheng SK; McKhann GM; Bruce JN; Lassman AB; Sisti MB Neurosurgery; 2016 May; 78(5):676-82. PubMed ID: 26440447 [TBL] [Abstract][Full Text] [Related]
28. Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme. Lee JH; Jung TY; Jung S; Kim IY; Jang WY; Moon KS; Jeong EH J Clin Neurosci; 2013 Apr; 20(4):503-8. PubMed ID: 23313530 [TBL] [Abstract][Full Text] [Related]
29. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015 [TBL] [Abstract][Full Text] [Related]
30. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
31. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136 [TBL] [Abstract][Full Text] [Related]
32. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma. Gramatzki D; Kickingereder P; Hentschel B; Felsberg J; Herrlinger U; Schackert G; Tonn JC; Westphal M; Sabel M; Schlegel U; Wick W; Pietsch T; Reifenberger G; Loeffler M; Bendszus M; Weller M Neurology; 2017 Apr; 88(15):1422-1430. PubMed ID: 28298550 [TBL] [Abstract][Full Text] [Related]
33. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ; Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895 [TBL] [Abstract][Full Text] [Related]
34. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience. Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151 [TBL] [Abstract][Full Text] [Related]
35. Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials? Fiorentino A; Balducci M; De Bonis P; Chiesa S; De Filippo L; Mangiola A; De Rose F; Autorino R; Rinaldi C; Fersino S; Diletto B; Matteucci P; Ciurlia E; Fusco V; Anile C; Valentini V Am J Clin Oncol; 2015 Feb; 38(1):23-7. PubMed ID: 23388566 [TBL] [Abstract][Full Text] [Related]
36. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084 [TBL] [Abstract][Full Text] [Related]
38. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base. Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053 [TBL] [Abstract][Full Text] [Related]
39. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119 [TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide. Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]